Post-earnings recap
Reported
Tue, Nov 4, 2025
EPS actual
$0.23
EPS est.
$0.15
EPS surprise
+48.39%
1-day move
+8.35%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported an earnings per share of $0.23, exceeding expectations significantly. This positive surprise likely contributed to the stock's 8.35% increase following the announcement. However, without revenue figures or guidance updates, investors may remain cautious about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.23 | N/A | +48.39% |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.